Identification of high- and low-risk second kidney grafts

Transplantation

Volumn 61, Issue 9, 1996, Pages 1349-1355

  Mahoney, Richard J ^a   Norman, Douglas J ^b   Colombe, Beth W ^c   Garovoy, Marvin R ^c   Leeber, Donald A ^d  

^a Maine Medical Center Research Institute   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT SURVIVAL; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; REOPERATION; RISK ASSESSMENT; SURVIVAL RATE;

FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0029879709     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00011     Document Type: Article

References (25)

1. Evans RW. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratories, 1993: 359.
2. Eggers P. Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992; 12: 284.
3. 1993 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Richmond, VA: UNOS, and Bethesda, MD: Division of Organ Transplantation, Health Resources and Services Administration.
4. Cho YW, Cecka JM. Cadaveric-donor renal retransplants. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratories, 1993: 469.
5. Mitsuiki Y, Cecka JM. Recent improvements in cadaver-donor kidney retransplantation. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratories, 1991: 281.
6. Gifford RRM, Sutherland DER, Fryd DS, Simmons RL, Najarian JS. Duration of first allograft survival as an indicator of second allograft outcome. Surgery 1980; 88: 611.
7. Cabacungan C. Regrafts. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratories, 1992: 347.
8. Almond PS, Matas AJ, Gillingham K, et al. Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 1991; 52: 253.
9. Opelz G. Influence of HLA matching on survival of second kidney transplants in cyclosporine-treated recipients. Transplantation 1989; 47: 623.
10. Mahoney RJ, Ault KA, Given SR, et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation 1990; 49: 527.
11. Mahoney RJ. Regraft survival in positive flow cytometric crossmatch patients by length of previous graft survival [Abstract]. In: Terasaki PI, ed. Visuals of the clinical histocompatibility workshop. Canoga Park, CA: One Lambda, Inc., 1990: 43.
12. Ogura K, Cecka JM. Cadaver retransplants. In: Terasaki PI, Ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Typing Laboratories, 1990: 471.
13. Thorogood J, Houwelingen JC, Persijn GG, et al. Prognostic indices to predict survival of first and second renal allografts. Transplantation 1991; 52: 831.
14. Cook DJ, Terasaki PI, Terashita GY, Lau M. An approach to reducing early kidney transplant failure by flow cytometry crossmatching. Clin Transplant 1987; 1: 253.
15. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21 (suppl 97): 51.
16. Danilovs JA, Ayoub G, Terasaki PI. B lymphocyte isolation by thrombin-nylon wool. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA, 1989: 287.
17. Fuller TC, Phelan D, Gebel H, Rodey GE. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytoxicity test. Transplantation 1982; 34: 24.
18. Staff, Transplantation and Immunology Branch, NIH. Lymphocyte microlymphocytotoxicity technique. In: Ray JG Jr, ed. NIAID manual of tissue typing techniques, 1979-1980 (U.S. DHEW Publication No. [NIH] 80-6545). Bethesda, MD: NIH, 1979: 39.
19. Ogura K, Terasaki PI, Johnson R, et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993; 56: 294.
20. Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analyses: a high technology crossmatch technique facilitating transplantation. Transplant Proc, 1983; 15: 1939.
21. Lazda VA. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch. Transplantation 1994; 57: 964.
22. Benedetti J, Yuen K, Young L. Life tables and survival functions. In: Dixon NJ, ed. BMDP statistical software. Berkeley, CA: University of California Press, 1985: 557.
23. Colombe B, Lou C, Melzer J, Tomlanovich S, Ascher N, Garovoy M. Improvement in graft survival of cadaveric kidneys in regrafted patients by flow cytometry crossmatching. In: Terasaki PI, ed. Visuals of the clinical histocompatibility workshop. Canoga Park, CA: One Lambda, Inc., 1994: 25.
24. Mitsuiski Y, Terasaki PI. Is repeated mismatch of HLA deleterious to second transplants? [Abstract] Hum Immunol 1992; 34 (Suppl): 46.
25. Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal retransplants - a second class mistake? Transplantation 1994; 57: 515.